Trial
NCT02356991
A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
Sun Yat-sen University; Shanghai Pulmonary Hospital, Shanghai, China
Condition
Non-Small Cell Lung Cancer (NSCLC)
Intervention
Famitinib
Why stopped
sponsor decides to suspend this trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-04